Immediate Impact

1 by Nobel laureates 2 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
2 intermediate papers

Works of Flora Mulkey being referenced

Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis
2020
Alliance A061202. a Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib Versus Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Refractory to Lenalidomide and Proteasome Inhibitor Based Therapy: Phase I Results
2015

Author Peers

Author Last Decade Papers Cites
Flora Mulkey 418 300 177 400 349 33 1.4k
Susan Kim 115 163 187 56 147 54 1.2k
S. Helweg‐Larsen 281 60 87 15 154 28 1.5k
Barbara Klein 183 263 376 12 127 38 1.2k
Louisa Ho 164 61 435 15 298 52 1.6k
Joseph M. Cash 99 183 128 10 122 26 1.3k
Nguyet Le‐Lindqwister 1115 299 151 7 472 29 1.6k
B. Jandolo 534 144 168 7 93 61 1.7k
Kristine Phillips 81 112 288 9 354 33 1.7k
Saliha Karatay 113 183 169 12 153 59 1.0k
Anna Proia 99 98 180 7 509 26 1.2k

All Works

Loading papers...

Rankless by CCL
2026